Crypto funds saw $1.4 billion in weekly inflows as US-Iran tensions eased, boosting market confidence. The improved geopolitical climate is fueling bullish trends and may influence future risk assessments in the crypto sector. The influx highlights increased investor optimism amid geopolitical stabilization, with the trend reflecting broader positive sentiment in the Web3 space.
Polymarket is seeking a $400 million funding round at a $15 billion valuation, with the total raise potentially reaching $1 billion amid increased competition from Kalshi on Wall Street. The company’s new funding push reflects growing investor interest in decentralized prediction markets, as Polymarket aims to expand its platform and market reach. The funding negotiations are ongoing as of April 2026.
AstraZeneca's COPD drug tozorakimab successfully met primary endpoints in the Phase III MIRANDA trial on April 20, 2026, reducing moderate-to-severe exacerbations compared to placebo. The drug, administered every two weeks, builds on positive results from earlier Phase III trials, OBERON and TITANIA. This milestone could advance to regulatory review, potentially impacting AstraZeneca’s stock.
Slovenian Prime Minister Robert Golob has been unable to form a coalition, leading to ongoing political deadlock as of April 2026. This impasse threatens to delay key pro-EU policies and could impact the country's economic stability. The deadlock underscores political instability in Slovenia, raising concerns about future policy progress and economic repercussions.
Iran has accused the US of bad faith, sharply reducing the chances of a peace deal and increasing tensions between the two nations. The escalating distrust threatens regional stability and could impact global relations. The situation highlights ongoing diplomatic challenges, with no specific dates or amounts involved, but the deteriorating relationship raises concerns for future negotiations.
Iranian parliament speaker Ghalibaf’s recent criticism has heightened internal discord, complicating efforts for a US-Iran peace deal by April 22. The remarks have also negatively impacted market confidence, making diplomatic progress more challenging. The internal disagreements within Iran are now seen as a significant obstacle to reaching an agreement between the two nations.
Polymarket aims to raise $400 million at a $15 billion valuation, signaling strong growth in blockchain prediction markets. The funding follows a $600 million investment from ICE in March, sparking debate over sector maturity versus speculation. The raise reflects investor confidence in Web3 prediction platforms and their potential mainstream adoption.
